Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Probiotic effects are strain-specific and individual responses vary. Consult a healthcare provider before starting any probiotic supplement, especially if you are immunocompromised, critically ill, or taking medications.
Introduction
Not all probiotics are created equal. The health effects of probiotics are strain-specific, meaning that two organisms within the same species can produce entirely different clinical outcomes.[1] Yet most consumers choose probiotics based on brand name or CFU count alone, without considering whether the specific strains in a product have evidence for their health goals.
This guide provides a comprehensive strain comparison chart to help you identify which probiotic strains have the best evidence for specific conditions — from digestive health to immune support to mental wellbeing.
How to Read This Chart
Each probiotic organism is classified by genus, species, and strain designation. For example, in Lactobacillus rhamnosus GG:
- Genus: Lactobacillus
- Species: rhamnosus
- Strain: GG
The strain designation matters most for clinical evidence. A product listing only "Lactobacillus rhamnosus" without a strain code may not deliver the same benefits as a product containing the well-studied GG strain.
Note on nomenclature: Several Lactobacillus species have been reclassified. L. rhamnosus is now Lacticaseibacillus rhamnosus, L. casei is now Lacticaseibacillus casei, and L. plantarum is now Lactiplantibacillus plantarum. We use the traditional names here for familiarity, with the understanding that product labels may reflect updated taxonomy.
Comprehensive Probiotic Strain Comparison Chart
Lactobacillus (and Reclassified) Strains
| Strain | Key Benefits | Best For | Evidence Level | Learn More |
|---|---|---|---|---|
| L. rhamnosus GG (LGG) | Prevents antibiotic-associated diarrhea, supports immune function, reduces acute diarrhea duration | Diarrhea prevention, pediatric gut health, immune support | Strong — hundreds of RCTs | L. rhamnosus |
| L. rhamnosus HN001 | May reduce eczema risk in infants, supports maternal mental health | Eczema prevention, pregnancy/postpartum | Moderate | L. rhamnosus |
| L. acidophilus NCFM | Reduces lactose intolerance symptoms, supports vaginal health, immune modulation | Lactose intolerance, general digestive health | Moderate | L. acidophilus |
| L. acidophilus La-5 | Improves stool frequency, supports cholesterol metabolism | Constipation, cardiovascular health | Moderate | L. acidophilus |
| L. casei Shirota | May improve mood and reduce anxiety, supports bowel regularity | Mood, constipation, immune support | Moderate | L. casei |
| L. casei DN-114 001 | Reduces antibiotic-associated diarrhea, supports immune function in elderly | Antibiotic-associated diarrhea, elderly immune health | Moderate | L. casei |
| L. plantarum 299v | Reduces IBS symptoms (bloating, pain), supports iron absorption | IBS, bloating, iron deficiency | Moderate | — |
| L. reuteri DSM 17938 | Reduces infant colic crying time, supports gut motility | Infant colic, functional GI disorders | Strong (pediatric) | — |
| L. helveticus R0052 | Reduces anxiety and depression scores (combined with B. longum R0175), lowers cortisol | Mental health, stress, gut-brain axis | Moderate | — |
Bifidobacterium Strains
| Strain | Key Benefits | Best For | Evidence Level | Learn More |
|---|---|---|---|---|
| B. longum BB536 | Supports immune function, reduces allergy symptoms, improves bowel regularity | Allergies, constipation, elderly health | Moderate | B. longum |
| B. longum R0175 | Reduces stress and anxiety (with L. helveticus R0052), supports gut-brain axis | Mental health, stress resilience | Moderate | B. longum |
| B. longum 35624 | Reduces IBS symptoms, modulates immune response | IBS (all subtypes), immune regulation | Moderate–Strong | B. longum |
| B. bifidum Rosell-71 | Supports gut barrier integrity, reduces cold and flu duration | Immune support, upper respiratory infections | Moderate | B. bifidum |
| B. adolescentis | Produces folate, supports fiber fermentation, associated with healthy aging | General microbiome diversity, metabolic health | Emerging | B. adolescentis |
| B. animalis subsp. lactis BB-12 | Improves bowel regularity, supports immune function, well-studied in infants | Constipation, pediatric health, immune support | Strong | — |
| B. animalis subsp. lactis HN019 | Reduces constipation and bloating, supports immune function in elderly | Functional constipation, elderly gut health | Moderate | — |
Saccharomyces Strains
| Strain | Key Benefits | Best For | Evidence Level | Learn More |
|---|---|---|---|---|
| S. boulardii CNCM I-745 | Prevents antibiotic-associated diarrhea, reduces C. difficile recurrence, treats acute diarrhea | Antibiotic-associated diarrhea, traveler's diarrhea, C. difficile | Strong — extensive meta-analyses | S. boulardii |
Bacillus (Spore-Forming) Strains
| Strain | Key Benefits | Best For | Evidence Level | Learn More |
|---|---|---|---|---|
| B. coagulans GBI-30, 6086 | Reduces IBS symptoms, improves protein digestion, shelf-stable | IBS, digestive comfort, sports nutrition | Moderate | — |
| B. subtilis DE111 | Supports immune function, improves lipid profiles, shelf-stable | General wellness, immune support | Emerging | B. subtilis |
| B. clausii O/C, SIN, N/R, T | Used widely in European and Asian medicine for diarrhea, antibiotic recovery | Acute diarrhea, antibiotic recovery | Moderate (regional) | — |
Key Principles for Choosing a Probiotic
1. Match the Strain to Your Goal
The most common mistake is choosing a probiotic based on generic claims rather than strain-specific evidence. If you are managing IBS, look for strains with IBS trial data (such as B. longum 35624 or L. plantarum 299v).[4] If preventing antibiotic-associated diarrhea, S. boulardii CNCM I-745 or L. rhamnosus GG have the strongest evidence.[2,3]
2. Verify the Strain Designation on the Label
A quality probiotic product should list the full strain designation — not just genus and species. If a label says only "Lactobacillus acidophilus" without a strain code, you cannot verify whether it matches strains used in clinical research.[7]
3. CFU Count Is Not Everything
Higher CFU counts do not necessarily mean greater efficacy. Most clinical trials use doses ranging from 1 billion to 100 billion CFU, and the effective dose varies by strain. L. rhamnosus GG is effective at 10 billion CFU for diarrhea prevention, while some Bifidobacterium strains show benefits at 1 billion CFU. See our CFU guide for more details.
4. Consider Delivery and Stability
Some strains require refrigeration (many Lactobacillus and Bifidobacterium strains), while spore-forming strains (Bacillus species) and yeast-based probiotics (Saccharomyces boulardii) are shelf-stable. Enteric coating or delayed-release capsules may improve survival through stomach acid, though not all strains require this protection.
5. Duration Matters
Most clinical trials show benefits after 4–8 weeks of daily use. Probiotic effects generally do not persist after discontinuation, as supplemented strains typically do not permanently colonize the gut.[7] Ongoing use may be necessary for sustained benefits.
Strains by Health Goal: Quick Reference
Antibiotic-associated diarrhea: S. boulardii CNCM I-745, L. rhamnosus GG
IBS: B. longum 35624, L. plantarum 299v, B. coagulans GBI-30 6086
Constipation: B. animalis subsp. lactis BB-12, B. animalis subsp. lactis HN019, L. casei Shirota
Mental health and stress: L. helveticus R0052 + B. longum R0175, L. casei Shirota
Immune support: L. rhamnosus GG, B. animalis subsp. lactis BB-12, B. bifidum Rosell-71
Infant colic: L. reuteri DSM 17938
Eczema prevention: L. rhamnosus HN001
Limitations and Caveats
Probiotic research has important limitations. Many studies are small, industry-funded, and vary in quality.[7] Effects observed in one population may not generalize to another. Individual responses depend on the person's existing microbiome, diet, genetics, and health status. What works for one person may not work for another.
Additionally, the probiotic field is evolving rapidly. Next-generation probiotics like Akkermansia muciniphila and Faecalibacterium prausnitzii are showing promise in early research but are not yet widely available as supplements.
The Bottom Line
Choosing the right probiotic means looking beyond the brand and the billion-CFU headline to focus on the specific strain and its evidence base for your health goal. The comparison chart above provides a starting point, but always discuss probiotic use with a healthcare provider — especially if you have underlying health conditions or take medications.
References
- Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.
- McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202-2222.
- Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12:CD006095.
- Ford AC, Quigley EMM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome. Am J Gastroenterol. 2014;109(10):1547-1561.
- Sanders ME, Merenstein DJ, Ouwehand AC, et al. Probiotic use in at-risk populations. J Am Pharm Assoc. 2016;56(6):680-686.
- Dimidi E, Christodoulides S, Fragkos KC, et al. The effect of probiotics on functional constipation in adults. Am J Clin Nutr. 2014;100(4):1075-1084.
- Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716-729.
Frequently Asked Questions
Do different probiotic strains do different things?
Yes. Probiotic effects are strain-specific, meaning that two strains within the same species can have very different clinical effects. For example, Lactobacillus rhamnosus GG has strong evidence for preventing antibiotic-associated diarrhea, while Lactobacillus rhamnosus HN001 has been studied primarily for eczema prevention in infants. Choosing a probiotic based on the specific strain — not just the genus or species — is important for targeting a particular health concern.
What is the most studied probiotic strain?
Lactobacillus rhamnosus GG (LGG) is one of the most extensively studied probiotic strains, with hundreds of clinical trials spanning over three decades. It has strong evidence for preventing and treating antibiotic-associated diarrhea, acute infectious diarrhea in children, and some evidence for supporting immune function. Saccharomyces boulardii CNCM I-745 is another extensively studied strain, particularly for diarrhea prevention.
Can I take multiple probiotic strains together?
Yes, many commercial products contain multiple strains, and some clinical trials have used multi-strain formulations. However, more strains do not automatically mean better results. The key is whether the specific combination has been studied for your health goal. Some strains may work synergistically, while others may compete. If possible, choose products whose exact multi-strain formulation has clinical evidence.
How do I read a probiotic label correctly?
A proper probiotic label should list: the genus (e.g., Lactobacillus), species (e.g., rhamnosus), and strain designation (e.g., GG). It should also state the CFU count guaranteed through the expiration date — not just at time of manufacture. Look for storage instructions, third-party testing seals, and a listed strain designation. If a product only lists genus and species without a strain code, it may be difficult to verify clinical evidence.
Are spore-based probiotics better than regular probiotics?
Spore-forming probiotics (like Bacillus coagulans and Bacillus subtilis) have the advantage of surviving stomach acid and heat without refrigeration, which may improve shelf stability. However, 'better' depends on the health outcome you're targeting. Spore-formers have growing evidence for digestive health and immune function, but Lactobacillus and Bifidobacterium strains have a much larger evidence base overall. The best probiotic is the one with clinical evidence for your specific concern.
References
- Hill C, Guarner F, Reid G, et al.. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11(8):506-514. doi:10.1038/nrgastro.2014.66
- McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology. 2010;16(18):2202-2222. doi:10.3748/wjg.v16.i18.2202
- Goldenberg JZ, Yap C, Lytvyn L, et al.. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews. 2017;12:CD006095. doi:10.1002/14651858.CD006095.pub4
- Ford AC, Quigley EMM, Lacy BE, et al.. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation. American Journal of Gastroenterology. 2014;109(10):1547-1561. doi:10.1038/ajg.2014.202
- Sanders ME, Merenstein DJ, Ouwehand AC, et al.. Probiotic use in at-risk populations. Journal of the American Pharmacists Association. 2016;56(6):680-686. doi:10.1016/j.japh.2016.07.001
- Dimidi E, Christodoulides S, Fragkos KC, et al.. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2014;100(4):1075-1084. doi:10.3945/ajcn.114.089151
- Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nature Medicine. 2019;25(5):716-729. doi:10.1038/s41591-019-0439-x